Skip to content
TrialScanner

NCT00597649

A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Phase 2TerminatedXTLBLead

Registry record

Lead sponsor
XTL Biopharmaceuticals
Conditions
Chronic Peripheral Neuropathy Pain in Diabetics
Primary completion
Dec 2008Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00597649 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00597649: A 52-Week Study of Bicifadine... | TrialScanner